Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Hisse Senetlerindeki Sıralama #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Hisse Fiyatı
$0.00244926
Piyasa Değeri
$51.67K
Değişim (1 gün)
5.88%
Değişim (1 yıl)
110.15%
Ülke
GB
Ticaret Nuformix plc (NFX)

Kategori

Nuformix plc (NFX) için kazanç
Sep 2025 itibarıyla kazanç TTM: $-5.28M
Nuformix plc şirketinin en son finansal raporlarına göre, mevcut kazancı $-5.28M'dir. 2024 yılında şirket $-4.88M kazanç elde etti, bu 2023 yılındaki $-754.56K kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Nuformix plc için kazanç geçmişi 2014 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-5.28M 494.63%
2025 $-888.01K -81.80%
2024 $-4.88M 546.72%
2023 $-754.56K -54.82%
2022 $-1.67M -11.94%
2021 $-1.90M 64.37%
2020 $-1.15M -51.92%
2019 $-2.40M -12.87%
2018 $-2.75M 220.48%
2017 $-859.40K 70.68%
2016 $-503.51K -206.04%
2014 $474.83K 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$20.46B -387,521.89%
DK
$4.64B -88,033.93%
US
$5.23B -99,160.13%
US
$2.14B -40,584.12%
BE
$1.61B -30,671.66%
AU